Back to PANAGORA ASSET MANAGEMENT INC PANAGORA ASSET MANAGEMENT INC

CLDXCLDX
21 quarters

Position history for PANAGORA ASSET MANAGEMENT INCPANAGORA ASSET MANAGEMENT INC's holdings in Celldex Therapeutics, Inc.

PANAGORA ASSET MANAGEMENT INC holds 572,538 shares of CLDX (Celldex Therapeutics, Inc.), worth $21.3M as of 2026-Q2. The position was increased (+302.3% shares). CLDX represents 0.1% of PANAGORA ASSET MANAGEMENT INC's portfolio.

Current Value

$21.3M

Current Shares

572,538

Total Value Change

+$21.3M

Total Shares Change

+472,181

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
572,538
+302.3%
$21.3M0.1%$37.21
46
2026-Q1
Increased
142,327
+551.2%
$4.5M0.0%$28.94
43
2025-Q4
Increased
21,856
+7.5%
$593,6090.0%$26.43
26
2025-Q3
Unchanged
20,334
0.0%
$526,0410.0%$26.19
0
2025-Q2
Decreased
20,334
-0.6%
$413,7970.0%$20.29
0
2025-Q1
Decreased
20,453
-82.3%
$371,2220.0%$19.93
0
2024-Q4
Decreased
115,633
-0.9%
$2.9M0.0%$25.12
0
2024-Q3
Decreased
116,674
-1.4%
$4M0.0%$33.20
0
2024-Q2
New
118,347
-
$4.4M0.0%$37.01
37
2021-Q3
Exited
0
-100.0%
$00.0%$51.97
0
2021-Q2
Decreased
1,150
-23.0%
$38,0000.0%$35.37
0
2021-Q1
Unchanged
1,493
0.0%
$31,0000.0%$19.73
0
2020-Q4
Decreased
1,493
-15.8%
$26,0000.0%$17.88
0
2020-Q3
Unchanged
1,774
0.0%
$26,0000.0%$15.19
0
2020-Q2
Unchanged
1,774
0.0%
$23,0000.0%$12.48
0
2020-Q1
Unchanged
1,774
0.0%
$3,0000.0%$1.77
0
2019-Q4
Unchanged
1,774
0.0%
$4,0000.0%$2.20
0
2019-Q3
Increased
1,774
+6.0%
$4,0000.0%$2.17
10
2019-Q2
Decreased
1,673
-75.0%
$4,0000.0%$2.68
0
2019-Q1
Decreased
6,690
-93.3%
$33,0000.0%$4.92
0
2018-Q4
New
100,357
-
$20,0000.0%$3.00
26

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used